Group | Frequentist Modelling

Students attending a course in statistics

The group operates the data centre of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA). It develops models for studying the long-term effects of air pollution on population health, and supports and supervises analyses conducted within SAPALDIA.

The group conducts time-series modelling of the short-term effects of air pollution and also contributes to the development of spatio-temporal models of air pollutants in Switzerland. Moreover, the group is linked to clinical research projects, notably in neurology, and specialised in supporting clinically oriented projects within the Swiss TPH data team. The group runs statistics courses for the medical curriculum and administers two master level courses in the Faculty of Science and in two postgraduate courses.

Castillo-Mancilla J.R et al. Association of incomplete adherence to antiretroviral therapy with cardiovascular events and mortality in virologically suppressed persons with HIV: the Swiss HIV cohort study. Open Forum Infect Dis. 2021;8(2):ofab032. DOI: 10.1093/ofid/ofab032

Glass T.R et al. The role of HIV asymptomatic status when starting ART on adherence and treatment outcomes and implications for test and treat: the Swiss HIV Cohort Study. Clin Infect Dis. 2021;72(8):1413-1421. DOI: 10.1093/cid/ciaa239

Mapesi H et al. The coArtHA trial—identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial. Trials. 2021;22:77. DOI: 10.1186/s13063-021-05023-z

Ramser M et al. Abdominal decompression after cardiac surgery: outcome of 42 patients with abdominal compartment syndrome. World J Surg. 2021;45(4):1242-1251. DOI: 10.1007/s00268-020-05917-0

Vanobberghen F et al. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallelgroup, open-label, randomised controlled phase 3 trial. Lancet Glob Health. 2021;9(2):e189-e198. DOI: 10.1016/S2214-109X(20)30448-4